Gilead Sciences Appoints Jacqueline K. Barton, Ph.D. to Board of Directors
6 February 2018 - - Foster City, California-based global research-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) has named Jacqueline K. Barton, Ph.D., to its board of directors, the company said.
She previously served on Gilead's scientific advisory board from 1989 to 2007.
Barton is the John G. Kirkwood and Arthur A. Noyes Professor of Chemistry and Norman Davidson Leadership chair of the Division of Chemistry and Chemical Engineering at the California Institute of Technology, where she has been a faculty member for nearly 30 years.
She served on the board of directors of the Dow Chemical company from 1993 to 2017, and currently is a member of the Materials Science Advisory Committee of DowDuPont, Inc. She founded and served on the board of GeneOhm Sciences, Inc., a molecular diagnostic company acquired by Becton Dickinson and company.
She is a member of the National Academy of Sciences, the National Academy of Medicine and the American Philosophical Society. In 2011, Barton received the National Medal of Science for her discovery of new chemistry of the DNA helix.
Gilead Sciences discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 40 countries worldwide.